Crinetics Pharmaceuticals

-$0.06 (-0.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRNX and other stocks, options, and ETFs commission-free!

About CRNX

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly.

CEO
Scott R. Struthers
Employees
93
Headquarters
San Diego, California
Founded
2008

CRNX Key Statistics

Market Cap
647.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
94.90K
High Today
$17.08
Low Today
$16.22
Open Price
$16.31
Volume
59.85K
52 Week High
$23.70
52 Week Low
$11.61

CRNX Earnings

-$0.71
-$0.47
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.66 per share
Actual
-$0.69 per share

You May Also Like

PEI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure